Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: BIS Research | PRODUCT CODE: 1056644

Cover Image

PUBLISHER: BIS Research | PRODUCT CODE: 1056644

NGS Sample Preparation Market - A Global and Regional Analysis: Focus on Product, Workflow, Therapeutic Area, Application, End User, and Region - Analysis and Forecast, 2021-2026

PUBLISHED:
PAGES: 294 Pages
DELIVERY TIME: 1-5 business days
SELECT AN OPTION
PDF and Excel (1-3 User License)
USD 5250
PDF and Excel (Global License)
USD 8100

Add to Cart

“Global NGS Sample Preparation Market to Reach $3,279.3 Million by 2026.”

Market Report Coverage - NGS Sample Preparation

Market Segmentation

  • Product (Consumables, Standalone Automation Instruments, Automated Workstation, Accessories and Components)
  • Workflow (Library Preparation, Target Enrichment, Sample Extraction/Isolation, Fragmentation, Sample Quantification, Library Quantification, Quality Control (QC), and Pooling)
  • Therapeutic Area (Oncology, Infectious Diseases, Human Genetics/Population Genetics, and Others)
  • Application (DNA Sequencing, Whole Genome Sequencing, RNA Sequencing, Methylation Sequencing, and Others)
  • End User (Hospitals and Clinics, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others)

Regional Segmentation

  • North America: U.S., Canada
  • Europe: Germany, France, U.K., Italy, Spain, Netherlands, Denmark, Belgium, Switzerland, and Rest-of-Europe
  • Asia-Pacific: China, Japan, India, South Korea, Australia, Singapore, and Rest-of-Asia-Pacific
  • Latin America: Brazil, Mexico, and Rest-of-Latin America
  • Rest-of-the-World

Market Growth Drivers

  • Increasing Use of NGS for Genetic Disorders
  • Technological Advancements in NGS Sample Preparation Methods
  • Rising Research Funding in the Field of Genomics

Market Challenges

  • High Cost of Automated NGS Sample Preparation Instruments
  • Dearth of Skilled Professionals and Lack of Infrastructure in Emerging Countries
  • Stringent Regulatory Standards

Market Opportunities

  • Adoption of Automated NGS Sample Preparation in the Emerging Markets
  • Rising Direct-to-Consumer Testing

Key Companies Profiled

Agilent Technologies, Inc., Aurora Biomed Inc., Danaher, Bio-Rad Laboratories, Inc., Eppendorf SE, Opentrons, BGI Group, Promega Corporation, Oxford Nanopore Technologies plc., F. Hoffmann-La Roche Ltd, Tecan Trading AG, Hamilton Company, PerkinElmer Inc., Illumina, Inc., Thermo Fisher Scientific Inc., New England Biolabs, QIAGEN, Pacific Biosciences of California, Inc.

Key Questions Answered in this Report:

  • How is NGS sample preparation revolutionizing oncology?
  • What are the major market drivers, challenges, and opportunities in the global NGS sample preparation market?
  • What are the underlying structures resulting in the emerging trends within the global NGS sample preparation market?
  • How is the COVID-19 pandemic impacting the global NGS sample preparation ecosystem?
  • What are the key development strategies that are being implemented by the major players in order to sustain themselves in the competitive market?
  • What are the key regulatory implications in developed and developing regions pertaining to the use of NGS sample preparation products?
  • What are the potential entry barriers expected to be faced by the companies willing to enter a particular region?
  • How is each segment of the market expected to grow during the forecast period 2021-2026, and what is the anticipated revenue to be generated by each of the segments? Following are the segments:
    • Product (Consumables, Standalone Automation Instruments, Automated Workstation, Accessories and Components)
    • Workflow (Library Preparation, Target Enrichment, Sample Extraction/Isolation, Fragmentation, Sample Quantification, Library Quantification, Quality Control (QC), and Pooling)
    • Application (DNA Sequencing, Whole Genome Sequencing, RNA Sequencing, Methylation Sequencing, and Others)
    • Therapeutic Area (Oncology, Infectious Diseases, Human Genetics/Population Genetics, and Others)
    • End User (Hospitals and Clinics, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others)
    • Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
  • What are the growth opportunities for the NGS sample preparation companies in the region of their operation?
  • Who are the leading players with significant offerings in the global NGS sample preparation market?
  • Which companies are anticipated to be highly disruptive in the future, and why?

Market Overview

The growth of the NGS sample preparation market is expected to be driven by the widespread use of NGS in diagnostic laboratories, which has enhanced the accuracy of genetic diagnostics with high consistency. Advanced genetic diagnostic techniques are being used for predictive genetic testing and prenatal diagnosis. As the number of people suffering from genetic disorders is increasing, the efficiency and consistency of the diagnostic screening tests are becoming more crucial. Faster results with minimum errors are required to effectively screen a genetic disorder. The automated NGS sample preparation enhances the consistency and throughput of sample preparation for genetic sequencing. The current market for NGS sample preparation is majorly dominated by manufacturers and service providers such as Thermo Fisher Scientific Inc, Illumina, Inc., BGI Group, Agilent Technologies, Inc., Aurora Biomed, Inc., F. Hoffmann-La Roche Ltd, OPENTRONS, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, Inc., Eppendorf AG, Oxford Nanopore Technologies plc., Tecan Trading AG , Hamilton Company, New England Biolabs (NEB), Danaher Corporation, and PerkinElmer, Inc.

The global NGS sample preparation market is projected to reach $3,279.3 million by 2026, growing from $1,468.9 million in 2020, at a CAGR of 14.24% during the forecast period 2021-2026.

Improvements in diagnostic methods for the diagnosis of genetic and chronic diseases are highly prioritized all across the globe. There are lots of advancements pertaining to the effective diagnosis of genetic diseases; however, there remains a lack of adoption of technologically advanced equipment in emerging economies. Most of the developing economies in the world still opt for manual instruments in the field of research and diagnostics on account of financial feasibility.

Competitive Landscape

The growth of the NGS sample preparation market can be majorly attributed to major manufacturers of NGS sample preparation products, along with the service providers, who are actively involved in undertaking significant business strategies to translate success in research and development into the commercial clinical setting. Enterprises, led by the market juggernauts, are frequently updating and developing their respective product and service portfolios with innovative solutions to sustain the high competition in the market. Additionally, competitors' activities also include several partnerships, collaborations, and joint ventures to expand individual product and service portfolios along with the global footprint. Based on region, North America holds the largest share in the market owing to the technological advancements in NGS sample preparation methods, improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. However, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period 2021-2026.

Product Code: BHP0753SB

Table of Contents

1 Markets

  • 1.1 Product Definition
  • 1.2 The Basic NGS Workflow
    • 1.2.1 Global NGS Sample Preparation Market Scenario
    • 1.2.2 Inclusion and Exclusion
  • 1.3 Market Scope
    • 1.3.1 Scope of the Study
    • 1.3.2 Key Questions Answered in the Report
  • 1.4 Market Overview
    • 1.4.1 Market Definition
    • 1.4.2 Market Footprint and Growth Potential, $Million, 2020-2026
    • 1.4.3 Disruption in Global NGS Sample Preparation Market Due to COVID-19
    • 1.4.4 Navigating Crisis Recovery and Looking to the Future

2 Industry Insights

  • 2.1 Industry Insights
    • 2.1.1 Legal Requirements and Framework in the U.S.
    • 2.1.2 The U.S. FDA Published Guidance:
    • 2.1.3 The U.S. FDA Regulations
    • 2.1.4 Legal Requirements and Framework in Europe
    • 2.1.5 Legal Requirements and Framework in Asia-Pacific
      • 2.1.5.1 China
      • 2.1.5.2 Japan
        • 2.1.5.2.1 Pharmaceuticals and Medical Devices Agency (PMDA)
        • 2.1.5.2.2 Ministry of Health, Labour, and Welfare (MHLW)
      • 2.1.5.3 India
  • 2.2 Industry Trends
    • 2.2.1 Preference for Automated NGS Sample Preparation Workstations Integrated with Quality Control (QC)
    • 2.2.2 Growing Trend for the Preference of Customized Automated NGS Sample Preparation Platforms
  • 2.3 Market Dynamics
    • 2.3.1 Impact Analysis
    • 2.3.2 Market Drivers
      • 2.3.2.1 Increasing Use of NGS for Genetic Disorders
      • 2.3.2.2 Technological Advancements in NGS Sample Preparation Methods
      • 2.3.2.3 Rising Research Funding in the Field of Genomics
    • 2.3.3 Market Restraints
      • 2.3.3.1 High Cost of Automated NGS Sample Preparation Instruments
      • 2.3.3.2 Dearth of Skilled Professionals and Lack of Infrastructure in Emerging Countries
      • 2.3.3.3 Stringent Regulatory Standards
    • 2.3.4 Market Opportunities
      • 2.3.4.1 Adoption of Automated NGS Sample Preparation in the Emerging Markets
      • 2.3.4.2 Rising Direct-to-Consumer Testing
    • 2.3.5 Opportunity (by Product)
      • 2.3.5.1 Workstations
      • 2.3.5.2 Consumables
    • 2.3.6 Opportunity (by Application)
      • 2.3.6.1 DNA Sequencing
      • 2.3.6.2 Metagenomics
    • 2.3.7 Opportunity (by Region)
      • 2.3.7.1 North America
      • 2.3.7.2 Asia-Pacific (APAC)

3 Competitive Landscape

  • 3.1 Overview
  • 3.2 Synergistic Activities
  • 3.3 Product Launches
  • 3.4 Mergers and Acquisitions
  • 3.5 Other Business Activities
  • 3.6 Market Share Analysis, 2019-2020
  • 3.7 Growth Share Analysis (Company)
  • 3.8 Growth Share Analysis by End User
  • 3.9 Growth Share Analysis by Region

4 Products

  • 4.1 Overview
  • 4.2 Consumables
    • 4.2.1 Sample Extraction and Isolation Kits
    • 4.2.2 Sample Purification Kits
    • 4.2.3 Library Preparation Kits
      • 4.2.3.1 DNA Library Preparation Kits
      • 4.2.3.2 RNA Library Preparation Kits
      • 4.2.3.3 Library Quantification
      • 4.2.3.4 Library Amplification
      • 4.2.3.5 FFPE DNA Kits
      • 4.2.3.6 ChIP-Seq Library Preparation
      • 4.2.3.7 Library Preparation Accessories
    • 4.2.4 Target Enrichment
    • 4.2.5 Cleanup and Selection Kits
    • 4.2.6 Microbiome DNA Enrichment
    • 4.2.7 Other Consumables
  • 4.3 Automated Workstation
    • 4.3.1 Open System
    • 4.3.2 Close System
  • 4.4 Standalone Automation Instruments
    • 4.4.1 Fragment Analyzer
    • 4.4.2 Nucleic Acid Extraction/Isolation System
    • 4.4.3 DNA Selection Instrument
    • 4.4.4 DNA/RNA Shearing Instruments
    • 4.4.5 Template Preparation Instruments
    • 4.4.6 Ultrasonicator/Sonicator
  • 4.5 Accessories and Components

5 Workflow

  • 5.1 Overview:
  • 5.2 Library Preparation
  • 5.3 Target Enrichment
  • 5.4 Sample Extraction/Isolation
  • 5.5 Fragmentation
  • 5.6 Sample Quantification
  • 5.7 Library Quantification
  • 5.8 Quality Control (QC)
  • 5.9 Pooling

6 Therapeutic Area

  • 6.1 Overview
  • 6.2 Oncology
  • 6.3 Infectious Diseases
  • 6.4 Human Genetics/Population Genetics
  • 6.5 Others

7 Application

  • 7.1 Overview
  • 7.2 DNA Sequencing
  • 7.3 Whole Genome Sequencing
  • 7.4 RNA Sequencing
  • 7.5 Methylation Sequencing
  • 7.6 Other Applications

8 End-User

  • 8.1 Overview
  • 8.2 Hospitals and Clinics
  • 8.3 Academic and Research Institutions
  • 8.4 Pharmaceutical and Biotechnology Companies
  • 8.5 Other End Users

9 Region

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 France
    • 9.3.3 U.K.
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Netherlands
    • 9.3.7 Denmark
    • 9.3.8 Switzerland
    • 9.3.9 Belgium
    • 9.3.10 Rest-of-Europe
  • 9.4 Asia-Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 Australia
    • 9.4.4 India
    • 9.4.5 South Korea
    • 9.4.6 Singapore
    • 9.4.7 Rest-of-Asia-Pacific
  • 9.5 Latin America (LATAM)
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest-of-Latin America
  • 9.6 Rest-of-the-World (RoW)

10 Company Profiles

  • 10.1 Overview
  • 10.2 Agilent Technologies, Inc.
    • 10.2.1 Company Overview
    • 10.2.2 Role of Agilent Technologies, Inc. in the Global NGS Sample Preparation Market
    • 10.2.3 Financials
    • 10.2.4 Key Insights About Financial Health of the Company
    • 10.2.5 SWOT Analysis
  • 10.3 Aurora Biomed Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Role of Aurora Biomed Inc. in the Global NGS Sample Preparation Market
    • 10.3.3 SWOT Analysis
  • 10.4 Danaher
    • 10.4.1 Company Overview
    • 10.4.2 Role of Danaher in the Global NGS Sample Preparation Market
    • 10.4.3 Financials
    • 10.4.4 Key Insights About Financial Health of the Company
    • 10.4.5 SWOT Analysis
  • 10.5 Bio-Rad Laboratories, Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Role of Bio-Rad Laboratories, Inc. in the Global NGS Sample Preparation market
    • 10.5.3 Financials
    • 10.5.4 Key Insights About Financial Health of the Company
    • 10.5.5 SWOT Analysis
  • 10.6 Eppendorf SE
    • 10.6.1 Company Overview
    • 10.6.2 Role of Eppendorf SE in the NGS Sample Preparation Market
    • 10.6.3 Financials
    • 10.6.4 Key Insights About Financial Health of the Company
    • 10.6.5 SWOT Analysis
  • 10.7 Opentrons
    • 10.7.1 Company Overview
    • 10.7.2 Role of Opentrons in the Global NGS Sample Preparation Market
    • 10.7.3 SWOT Analysis
  • 10.8 BGI Group
    • 10.8.1 Company Overview
    • 10.8.2 Role of BGI Group in the Global NGS Sample Preparation Market
    • 10.8.3 SWOT Analysis
  • 10.9 Promega Corporation
    • 10.9.1 Company Overview
    • 10.9.2 Role of Promega Corporation in the Global NGS Sample Preparation Market
    • 10.9.3 SWOT Analysis
  • 10.1 Oxford Nanopore Technologies plc.
    • 10.10.1 Company Overview
    • 10.10.2 Role of Oxford Nanopore Technologies plc. In the Global NGS Sample Preparation Market
    • 10.10.3 Financials
    • 10.10.4 Key Insights About Financial Health of the Company
    • 10.10.5 SWOT Analysis
  • 10.11 F. Hoffmann-La Roche Ltd
    • 10.11.1 Company Overview
    • 10.11.2 Role of F. Hoffmann-La Roche Ltd in the Global NGS Sample Preparation Market
    • 10.11.3 Financials
    • 10.11.4 Key Insights About Financial Health of the Company
    • 10.11.5 SWOT Analysis
  • 10.12 Tecan Trading AG
    • 10.12.1 Company Overview
    • 10.12.2 Role of Tecan Trading AG in the Global NGS Sample Preparation Market
    • 10.12.3 Financials
    • 10.12.4 Key Insights About Financial Health of the Company
    • 10.12.5 SWOT Analysis
  • 10.13 Hamilton Company
    • 10.13.1 Company Overview
    • 10.13.2 Role of Hamilton Company in the Global NGS Sample Preparation Market
    • 10.13.3 SWOT Analysis
  • 10.14 PerkinElmer Inc.
    • 10.14.1 Company Overview
    • 10.14.2 Role of PerkinElmer Inc. in the Global NGS Sample Preparation Market
    • 10.14.3 Financials
    • 10.14.4 Key Insights About Financial Health of the Company
    • 10.14.5 SWOT Analysis
  • 10.15 Illumina, Inc.
    • 10.15.1 Company Overview
    • 10.15.2 Role of Illumina, Inc. in the Global NGS Sample Preparation Market
    • 10.15.3 Financials
    • 10.15.4 Key Insights About Financial Health of the Company
    • 10.15.5 SWOT Analysis
  • 10.16 Thermo Fisher Scientific Inc.
    • 10.16.1 Company Overview
    • 10.16.2 Role of Thermo Fisher Scientific Inc. in the Global NGS Sample Preparation Market
    • 10.16.3 Financials
    • 10.16.4 Key Insights About Financial Health of the Company
    • 10.16.5 SWOT Analysis
  • 10.17 New England Biolabs.
    • 10.17.1 Company Overview
    • 10.17.2 Role of New England Biolabs. in the Global Next-Generation Sequencing Sample Preparation Market
    • 10.17.3 SWOT Analysis
  • 10.18 QIAGEN
    • 10.18.1 Company Overview
    • 10.18.2 Role of QIAGEN in the Global NGS Sample Preparation Market
    • 10.18.3 Financials
    • 10.18.4 Key Insights About Financial Health of the Company
    • 10.18.5 SWOT Analysis
  • 10.19 Pacific Biosciences of California, Inc.
    • 10.19.1 Company Overview
    • 10.19.2 Role of Pacific Biosciences of California, Inc. in the Global NGS Sample Preparation Market
    • 10.19.3 Financials
    • 10.19.4 Key Insights About Financial Health of the Company
    • 10.19.5 SWOT Analysis
Product Code: BHP0753SB

List of Figures

  • Figure 1: Global Cancer Burden, 2020
  • Figure 2: Distribution of Deaths Due to People Suffering from Cystic Fibrosis (CF), 2019
  • Figure 3: Global NGS Sample Preparation Market (by Product), $Million, 2020 and 2026
  • Figure 4: Global NGS Sample Preparation Market (by Workflow), $Million, 2020 and 2026
  • Figure 5: Global NGS Sample Preparation Market (by Application), $Million, 2020 and 2026
  • Figure 6: Global NGS Sample Preparation Market (by Therapeutic Area), $Million, 2020 and 2026
  • Figure 7: Global NGS Sample Preparation Market (by End User), $Million, 2020 and 2026
  • Figure 8: Global NGS Sample Preparation Market Snapshot
  • Figure 9: Global NGS Sample Preparation Market: Research Methodology
  • Figure 10: Primary Research Methodology
  • Figure 11: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 12: Top-Down Approach (Segment-Wise Analysis)
  • Figure 13: Global NGS Sample Preparation Market, 2020-2026
  • Figure 14: Global NGS Sample Preparation Market Segmentation
  • Figure 15: Global NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 16: Global NGS Sample Preparation Market: COVID-19 Impact Analysis
  • Figure 17: FDA's Regulatory Insight System
  • Figure 18: Global NGS Sample Preparation Market Dynamics
  • Figure 19: Deaths Due to Cystic Fibrosis (CF), 2019
  • Figure 20: China Healthcare Expenditure (% of GDP), 2010-2018
  • Figure 21: Share of Key Developments and Strategies, January 2018-November 2021
  • Figure 22: Share of Synergistic Activities (by Company), January 2018-November 2021
  • Figure 23: Number of Product Launches (by Company), January 2018-November 2021
  • Figure 24: Share of Mergers and Acquisitions (by Company), January 2018-November 2021
  • Figure 25: Market Share Analysis for Global NGS Sample Preparation Market, $Million, 2019 and 2020
  • Figure 26: Growth Share Analysis for Global NGS Sample Preparation Market (by Company), 2020
  • Figure 27: Growth Share Matrix for Global NGS Sample Preparation Market (by End User), 2020
  • Figure 28: Growth Share Matrix for Global NGS Sample Preparation Market (by Region), 2020
  • Figure 29: Global NGS Sample Preparation Market (by Product)
  • Figure 30: Global NGS Sample Preparation Market (by Product), $Million, 2020 and 2026
  • Figure 31: Global NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
  • Figure 32: Global NGS Sample Preparation Market (Sample Extraction and Isolation Kits), $Million, 2020-2026
  • Figure 33: Global NGS Sample Preparation Market (Sample Purification Kits), $Million, 2020-2026
  • Figure 34: Global NGS Sample Preparation Market (Library Preparation Kits), $Million, 2020-2026
  • Figure 35: Global NGS Sample Preparation Market (DNA Library Preparation Kits), $Million, 2020-2026
  • Figure 36: Global NGS Sample Preparation Market (RNA Library Preparation Kits), $Million, 2020-2026
  • Figure 37: Global NGS Sample Preparation Market (Library Quantification), $Million, 2020-2026
  • Figure 38: Global NGS Sample Preparation Market (Library Amplification), $Million, 2020-2026
  • Figure 39: Global NGS Sample Preparation Market (FFPE DNA Kits), $Million, 2020-2026
  • Figure 40: Global NGS Sample Preparation Market (ChIP-Seq Library Preparation), $Million, 2020-2026
  • Figure 41: Global NGS Sample Preparation Market (Library Preparation Accessories), $Million, 2020-2026
  • Figure 42: Global NGS Sample Preparation Market (Target Enrichment), $Million, 2020-2026
  • Figure 43: Global NGS Sample Preparation Market (Cleanup and Selection Kits), $Million, 2020-2026
  • Figure 44: Global NGS Sample Preparation Market (Microbiome DNA Enrichment), $Million, 2020-2026
  • Figure 45: Global NGS Sample Preparation Market (Other Consumables), $Million, 2020-2026
  • Figure 46: Global NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
  • Figure 47: Global NGS Sample Preparation Market (Open System), $Million, 2020-2026
  • Figure 48: Global NGS Sample Preparation Market (Close System), $Million, 2020-2026
  • Figure 49: Global NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
  • Figure 50: Global NGS Sample Preparation Market (Fragment Analyzer), $Million, 2020-2026
  • Figure 51: Global NGS Sample Preparation Market (Nucleic Acid Extraction/Isolation System), $Million, 2020-2026
  • Figure 52: Global NGS Sample Preparation Market (DNA Selection Instrument), $Million, 2020-2026
  • Figure 53: Global NGS Sample Preparation Market (DNA/RNA Shearing Instruments), $Million, 2020-2026
  • Figure 54: Global NGS Sample Preparation Market (Template Preparation Instruments), $Million, 2020-2026
  • Figure 55: Global NGS Sample Preparation Market (Ultrasonicator/Sonicator), $Million, 2020-2026
  • Figure 56: Global NGS Sample Preparation Accessories and Components Market, $Million, 2020-2026
  • Figure 57: Global NGS Sample Preparation Market (Workflow)
  • Figure 58: Global NGS Sample Preparation Market (Library Preparation), $Million, 2020-2026
  • Figure 59: Global NGS Sample Preparation Market (Target Enrichment), $Million, 2020-2026
  • Figure 60: Global NGS Sample Preparation Market (Sample Extraction/Isolation), $Million, 2020-2026
  • Figure 61: Global NGS Sample Preparation Market (Fragmentation), $Million, 2020-2026
  • Figure 62: Global NGS Sample Preparation Market (Sample Quantification), $Million, 2020-2026
  • Figure 63: Global NGS Sample Preparation Market (Library Quantification), $Million, 2020-2026
  • Figure 64: Global NGS Sample Preparation Market (Quality Control (QC)), $Million, 2020-2026
  • Figure 65: Global NGS Sample Preparation Market (Pooling), $Million, 2020-2026
  • Figure 66: Share of Global NGS Sample Preparation Market (by Therapeutic Area), $Million 2020 and 2026
  • Figure 67: Global NGS Sample Preparation Market (Oncology), $Million, 2020-2026
  • Figure 68: Global NGS Sample Preparation Market (Infectious Diseases), $Million, 2020-2026
  • Figure 69: Global NGS Sample Preparation Market (Human Genetics/Population Genetics), $Million, 2020-2026
  • Figure 70: Global NGS Sample Preparation Market (Others), $Million, 2020-2026
  • Figure 71: Share of Global NGS Sample Preparation Market (by Application), $Million, 2020 and 2026
  • Figure 72: Global NGS Sample Preparation Market (DNA Sequencing), $Million, 2020-2026
  • Figure 73: Global NGS Sample Preparation Market (Whole Genome Sequencing), $Million, 2020-2026
  • Figure 74: Global NGS Sample Preparation Market (RNA Sequencing), $Million, 2020-2026
  • Figure 75: Global NGS Sample Preparation Market (Methylation Sequencing), $Million, 2020-2026
  • Figure 76: Global NGS Sample Preparation Market (Other Applications), $Million, 2020-2026
  • Figure 77: Global NGS Sample Preparation Market (by End User), $Million, 2020- 2026
  • Figure 78: Global NGS Sample Preparation Market (Hospitals and Clinics), $Million, 2020-2026
  • Figure 79: Global NGS Sample Preparation Market (Academic and Research Institutions), $Million, 2020-2026
  • Figure 80: Global NGS Sample Preparation Market (Pharmaceutical and Biotechnology Companies), $Million, 2020-2026
  • Figure 81: Global NGS Sample Preparation Market (Other End Users), $Million, 2020-2026
  • Figure 82: Global NGS Sample Preparation Market (by Region), $Million, 2021-2026
  • Figure 83: Share of North America NGS Sample Preparation Market Revenue (by Country), $Million, 2020 and 2026
  • Figure 84: North America: Market Dynamics
  • Figure 85: North America NGS Sample Preparation Market (by Country), $Million, 2020-2026
  • Figure 86: U.S. NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 87: U.S. NGS Sample Preparation Market (by Product), $Million, 2020-2026
  • Figure 88: U.S. NGS Sample Preparation Market, (by Automated Workstation), $Million, 2020-2026
  • Figure 89: U.S. NGS Sample Preparation Market, (by Standalone Automation Instruments), $Million, 2020-2026
  • Figure 90: U.S. NGS Sample Preparation Market, (by Consumables), $Million, 2020-2026
  • Figure 91: Canada NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 92: Canada NGS Sample Preparation Market (by Product), $Million, 2020-2026
  • Figure 93: Canada NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
  • Figure 94: Canada NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
  • Figure 95: Canada NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
  • Figure 96: Europe NGS Sample Preparation Market (by Country), $Million, 2020 and 2026
  • Figure 97: Europe: Market Dynamics
  • Figure 98: Europe NGS Sample Preparation Market (by Country), $Million, 2020-2026
  • Figure 99: Germany NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 100: Germany NGS Sample Preparation Market (by Product), $Million, 2020-2026
  • Figure 101: Germany NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
  • Figure 102: Germany NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
  • Figure 103: Germany NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
  • Figure 104: France NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 105: France NGS Sample Preparation Market (by Product), $Million, 2020-2026
  • Figure 106: France NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
  • Figure 107: France NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
  • Figure 108: France NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
  • Figure 109: U.K. NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 110: U.K. NGS Sample Preparation Market (by Product), $Million, 2020-2026
  • Figure 111: U.K. NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
  • Figure 112: U.K. NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
  • Figure 113: U.K. NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
  • Figure 114: Italy NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 115: Italy NGS Sample Preparation Market (by Product), $Million, 2020-2026
  • Figure 116: Italy NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
  • Figure 117: Italy NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
  • Figure 118: Italy NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
  • Figure 119: Spain NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 120: Spain NGS Sample Preparation Market (by Product), $Million, 2020-2026
  • Figure 121: Spain NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
  • Figure 122: Spain NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
  • Figure 123: Spain NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
  • Figure 124: Netherlands NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 125: Denmark NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 126: Switzerland NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 127: Belgium NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 128: Rest-of-Europe NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 129: Rest-of-Europe NGS Sample Preparation Market (by Product), $Million, 2020-2026
  • Figure 130: Rest-of-Europe NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
  • Figure 131: Rest-of-Europe NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
  • Figure 132: Rest-of-Europe NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
  • Figure 133: APAC: Market Dynamics
  • Figure 134: Asia-Pacific NGS Sample Preparation Market (by Country), $Million, 2020 and 2026
  • Figure 135: China NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 136: China NGS Sample Preparation Market (by Product), $Million, 2020-2026
  • Figure 137: China NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
  • Figure 138: China NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
  • Figure 139: China NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
  • Figure 140: Japan NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 141: Japan NGS Sample Preparation Market (by Product), $Million, 2020-2026
  • Figure 142: Japan NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
  • Figure 143: Japan NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
  • Figure 144: Japan NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
  • Figure 145: Australia NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 146: Australia NGS Sample Preparation Market (by Product), $Million, 2020-2026
  • Figure 147: Australia NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
  • Figure 148: Australia NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
  • Figure 149: Australia NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
  • Figure 150: India NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 151: India NGS Sample Preparation Market (by Product), $Million, 2020-2026
  • Figure 152: India NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
  • Figure 153: India NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
  • Figure 154: India NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
  • Figure 155: South Korea NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 156: South Korea NGS Sample Preparation Market (by Product), $Million, 2020-2026
  • Figure 157: South Korea NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
  • Figure 158: South Korea NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
  • Figure 159: South Korea NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
  • Figure 160: Singapore NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 161: Singapore NGS Sample Preparation Market (by Product), $Million, 2020-2026
  • Figure 162: Singapore NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
  • Figure 163: Singapore NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
  • Figure 164: Singapore NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
  • Figure 165: Rest-of-Asia-Pacific NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 166: Rest-of-Asia-Pacific NGS Sample Preparation Market (by Product), $Million, 2020-2026
  • Figure 167: Rest-of-Asia-Pacific NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
  • Figure 168: Rest-of-Asia-Pacific NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
  • Figure 169: Rest-of-Asia-Pacific NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
  • Figure 170: LATAM: Market Dynamics
  • Figure 171: Latin America NGS Sample Preparation Market (by Country), $Million 2020 and2026
  • Figure 172: Brazil NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 173: Brazil NGS Sample Preparation Market (by Product), $Million, 2020-2026
  • Figure 174: Brazil NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
  • Figure 175: Brazil NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
  • Figure 176: Brazil NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
  • Figure 177: Mexico NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 178: Mexico NGS Sample Preparation Market (by Product), $Million, 2020-2026
  • Figure 179: Mexico NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
  • Figure 180: Mexico NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
  • Figure 181: Mexico NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
  • Figure 182: Rest-of-Latin America NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 183: Rest-of-Latin America NGS Sample Preparation Market (by Product), $Million, 2020-2026
  • Figure 184: Rest-of-Latin America NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
  • Figure 185: Rest-of-Latin America NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
  • Figure 186: Rest-of-Latin America NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
  • Figure 187: Rest-of-the-World NGS Sample Preparation Market, $Million, 2020-2026
  • Figure 188: Total Number of Companies Profiled
  • Figure 189: Agilent Technologies, Inc.: Product Portfolio
  • Figure 190: Agilent Technologies, Inc.: Overall Financials, 2018-2020
  • Figure 191: Agilent Technologies, Inc.: Revenue (by Segment), 2018-2020
  • Figure 192: Agilent Technologies, Inc.: Revenue (by Region), 2018-2020
  • Figure 193: Agilent Technologies, Inc.: R&D Expenditure, 2018-2020
  • Figure 194: Agilent Technologies, Inc.: SWOT Analysis
  • Figure 195: Aurora Biomed Inc.: Overall Product Portfolio
  • Figure 196: Aurora Biomed Inc.: SWOT Analysis
  • Figure 197: Danaher: Product Portfolio
  • Figure 198: Danaher: Overall Financials, 2018-2020
  • Figure 199: Danaher: Revenue (by Business Segment), 2018-2020
  • Figure 200: Danaher: Revenue (by Region), 2018-2020
  • Figure 201: Danaher: R&D Expenditure, 2018-2020
  • Figure 202: Danaher Corporation: SWOT Analysis
  • Figure 203: Bio-Rad Laboratories, Inc.: Product Portfolio
  • Figure 204: Bio-Rad Laboratories, Inc.: Overall Financials, $Million, 2018-2020
  • Figure 205: Bio-Rad Laboratories, Inc.: Revenue (by Segment), $Million, 2018-2020
  • Figure 206: Bio-Rad Laboratories, Inc.: Revenue (by Region), $Million, 2018-2020
  • Figure 207: Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2018-2020
  • Figure 208: Bio-Rad Laboratories, Inc.: SWOT Analysis
  • Figure 209: Eppendorf SE: Overall Product Portfolio
  • Figure 210: Eppendorf SE: Overall Financials, 2018-2020
  • Figure 211: Eppendorf SE: Revenue (by Region), 2018-2020
  • Figure 212: Eppendorf AG: R&D Expenditure, 2018-2020
  • Figure 213: Eppendorf SE: SWOT Analysis
  • Figure 214: Opentrons.: Product Offerings
  • Figure 215: Opentrons: SWOT Analysis
  • Figure 216: BGI Group: Product Portfolio
  • Figure 217: BGI Group: SWOT Analysis
  • Figure 218: Promega Corporation: Product Portfolio
  • Figure 219: Promega Corporation: SWOT Analysis
  • Figure 220: Oxford Nanopore Technologies plc.: Product Offerings
  • Figure 221: Oxford Nanopore Technologies plc: Overall Financials, $Million, 2018-2020
  • Figure 222: Oxford Nanopore Technologies plc: Revenue (by Segment), $Million, 2018-2020
  • Figure 223: Oxford Nanopore Technologies plc: Revenue (by Region), $Million, 2018-2020
  • Figure 224: Oxford Nanopore Technologies plc.: R&D Expenditure, $Million, 2018-2020
  • Figure 225: Oxford Nanopore Technologies plc: SWOT Analysis
  • Figure 226: F. Hoffmann-La Roche Ltd: Product Portfolio
  • Figure 227: F. Hoffmann-La Roche Ltd: Overall Financials, 2018-2020
  • Figure 228: F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2018-2020
  • Figure 229: F. Hoffmann-La Roche Ltd: Revenue (by Region), 2018-2020
  • Figure 230: F. Hoffmann La-Roche Ltd.: R&D Expenditure, 2018-2020
  • Figure 231: F. Hoffmann-La Roche Ltd: SWOT Analysis
  • Figure 232: Product Portfolio: Tecan Trading AG
  • Figure 233: Tecan Trading AG: Overall Financials, 2018-2020
  • Figure 234: Tecan Trading AG: R&D Expenditure, 2018-2020
  • Figure 235: Tecan Trading AG: SWOT Analysis
  • Figure 236: Hamilton Company: Overall Product Portfolio
  • Figure 237: Hamilton Company: SWOT Analysis
  • Figure 238: PerkinElmer Inc.: Product Portfolio
  • Figure 239: PerkinElmer Inc.: Overall Financials, (2018-2020)
  • Figure 240: PerkinElmer Inc.: Revenue (by Business Segment), 2018-2020
  • Figure 241: PerkinElmer, Inc.: Revenue (by Region), 2018-2020
  • Figure 242: PerkinElmer, Inc.: R&D Expenditure, 2018-2020
  • Figure 243: PerkinElmer, Inc.: SWOT Analysis
  • Figure 244: Illumina, Inc. Product Portfolio
  • Figure 245: Illumina, Inc. Overall Financials, 2018-2020
  • Figure 246: Illumina, Inc. Revenue (by Segment), 2018-2020
  • Figure 247: Illumina, Inc. Revenue (by Region), 2018-2020
  • Figure 248: Illumina Inc.: R&D Expenditure, 2018-2020
  • Figure 249: Illumina, Inc.: SWOT Analysis
  • Figure 250: Thermo Fisher Scientific Inc.: Product Portfolio
  • Figure 251: Thermo Fisher Scientific Inc.: Overall Financials, 2018-2020
  • Figure 252: Thermo Fisher Scientific Inc.: Revenue (by Geographical Region), 2018-2020
  • Figure 253: Thermo Fisher Scientific Inc.: R&D Expenditure, 2018-2020
  • Figure 254: Thermo Fisher Scientific Inc.: SWOT Analysis
  • Figure 255: New England Biolabs.: Product Portfolio
  • Figure 256: New England Biolabs.: SWOT Analysis
  • Figure 257: QIAGEN: Product Portfolio
  • Figure 258: QIAGEN: Overall Financials, 2018-2020
  • Figure 259: QIAGEN: Revenue (by Segment), 2018-2020
  • Figure 260: QIAGEN: Revenue (by Region), 2018-2020
  • Figure 261: QIAGEN: R&D Expenditure, 2018-2020
  • Figure 262: QIAGEN: SWOT Analysis
  • Figure 263: Pacific Biosciences of California, Inc.: Product Portfolio
  • Figure 264: Pacific Biosciences of California, Inc.: Overall Financials, $Million, 2018-2020
  • Figure 265: Pacific Biosciences of California, Inc.: Revenue (by Segment), $Million, 2018-2020
  • Figure 266: Pacific Biosciences of California, Inc.: Revenue (by Region), $Million, 2018-2020
  • Figure 267: Pacific Biosciences of California, Inc.: R&D Expenditure, $Million, 2018-2020
  • Figure 268: Pacific Biosciences of California, Inc.: SWOT Analysis

List of Tables

  • Table 1: Impact Analysis of Market Drivers and Market Challenges in the Global NGS Sample Preparation Market
  • Table 2: Approved Next-Generation Sequencing (NGS) Panels in Japan
  • Table 3: Cost of NGS Per Sample on Different Applications
  • Table 4: Companies Providing Sample Extraction and Isolation Kits
  • Table 5: Companies Providing Library Preparation Kits
  • Table 6: Companies Providing Target Enrichment Kits
  • Table 7: Companies Offering Automated Workstation
  • Table 8: Companies Offering Standalone Automation Instruments
  • Table 9: Companies and their Therapeutic Areas for NGS Sample Preparation
  • Table 10: Companies and their Application in NGS Sample Preparation
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!